Real-world injection burden, treatment switching, and visual outcomes in diabetic macular edema: a 563-eye cohort study

This publication has 17 references indexed in Scilit:

• Systematic review: non-adherence and non-persistence in intravitreal treatment
  Graefe's Archive for Clinical and Experimental Ophthalmology, 2020
• HAWK and HARRIER: Phase 3, Multicenter, Randomized, Double-Masked Trials of Brolucizumab for Neovascular Age-Related Macular Degeneration
  Ophthalmology, 2020
• Anti–Vascular Endothelial Growth Factor Treatment for Diabetic Macular Edema in a Real-World Clinical Setting
  American Journal of Ophthalmology, 2018
• Real-World Outcomes of Ranibizumab Treatment for Diabetic Macular Edema in a United Kingdom National Health Service Setting
  American Journal of Ophthalmology, 2016
• Intravitreal Aflibercept for Diabetic Macular Edema
  Ophthalmology, 2016
• Disorganization of the Retinal Inner Layers as a Predictor of Visual Acuity in Eyes With Center-Involved Diabetic Macular Edema
  JAMA Ophthalmology, 2014
• The Neovascular Age-Related Macular Degeneration Database: Multicenter Study of 92 976 Ranibizumab Injections
  Ophthalmology, 2014
• Clinical Utilization of Anti-VEGF Agents and Disease Monitoring in Neovascular Age-Related Macular Degeneration
  American Journal of Ophthalmology, 2014
• Ranibizumab for Diabetic Macular Edema
  Ophthalmology, 2012
• Randomized Trial Evaluating Ranibizumab Plus Prompt or Deferred Laser or Triamcinolone Plus Prompt Laser for Diabetic Macular Edema
  Ophthalmology, 2010